Abstract: The present invention provides polynucleotides derived from cDNA of novel type of hepatitis C virus named Korean type hepatitis C virus (KHCV), polypeptides encoded therein, and antibodies directed against the polypeptides; and also provide diagnostics and vaccines employing any of the above materials as active ingredient(s).
Type:
Grant
Filed:
April 20, 1994
Date of Patent:
March 25, 2003
Assignee:
Lucky Limited
Inventors:
Joong Myung Cho, Yong Beom Lee, Young Woo Park, Kook Jin Lim, Deog Young Choi, Hong Seob So, Chun Hyung Kim, Sung Taek Kim, Jae Young Yang